Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |